VSee Health, Inc. (VSEEW) Latest Company News

Aug 31, 2026, 20:20 UTC
Scott Metzger resigned as a member of the Board of Directors of VSee Health, Inc., effective August 27, 2026.
Aug 27, 2026, 13:30 UTC
VSee Health announced approximately $1 million in near-term annual savings from transitioning off Nasdaq, cutting public-company expenses, and streamlining operations, with plans to redirect savings to growth initiatives.
Source:
- accessnewswire.com
Jul 29, 2026, 12:30 UTC
VSee Health, Inc. entered into a non-binding letter of intent to acquire certain healthcare technology and operating assets that support an integrated healthcare commerce platform for the U.S. clinic-based wellness market, valued at $42 million.
Source:
- accessnewswire.com
- accessnewswire.com
Jul 24, 2026, 00:00 UTC
VSEE Health, Inc. issued 1,000,000 restricted common shares and two convertible promissory notes to settle outstanding debt disputes with ADI Funding LLC and M2B Funding Corp., exempt from registration under Section 4(a)(2) and/or Regulation D.
Jun 22, 2026, 12:30 UTC
VSee Health completed the strategic sale of VSee Lab on May 31, 2026.
Source:
- accessnewswire.com
Jun 11, 2026, 12:30 UTC
VSee Health completed the sale of its subsidiary VSee Lab to former Co-CEO Milton Chen, retired approximately 7% of outstanding shares, and transitioned to single CEO leadership.
Source:
- accessnewswire.com
Jun 11, 2026, 00:00 UTC
VSee Health, Inc. signed a Standby Equity Purchase Agreement on June 2, 2026, for the sale of up to $10 million of its common stock in a private placement under Section 4(a)(2) of the Securities Act of 1933.

VSEEW

Scott Metzger resigned as a member of the Board of Directors of VSee Health, Inc., effective August 27, 2026.

VSee Health announced approximately $1 million in near-term annual savings from transitioning off Nasdaq, cutting public-company expenses, and streamlining operations, with plans to redirect savings to growth initiatives.

VSee Health, Inc. entered into a non-binding letter of intent to acquire certain healthcare technology and operating assets that support an integrated healthcare commerce platform for the U.S. clinic-based wellness market, valued at $42 million.

VSEE Health, Inc. issued 1,000,000 restricted common shares and two convertible promissory notes to settle outstanding debt disputes with ADI Funding LLC and M2B Funding Corp., exempt from registration under Section 4(a)(2) and/or Regulation D.

VSee Health completed the strategic sale of VSee Lab on May 31, 2026.

VSee Health completed the sale of its subsidiary VSee Lab to former Co-CEO Milton Chen, retired approximately 7% of outstanding shares, and transitioned to single CEO leadership.

VSee Health, Inc. signed a Standby Equity Purchase Agreement on June 2, 2026, for the sale of up to $10 million of its common stock in a private placement under Section 4(a)(2) of the Securities Act of 1933.